Myocardial Infarction News and Research

RSS

RAAS inhibitors are safe to use in COVID-19 patients, study shows

The coronavirus disease (COVID-19) is a novel illness that has spread across the globe in just five months. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral infection binds to the angiotensin-converting enzyme 2 (ACE2) to enter and invade cells.

21 May 2020

Precision medicine can determine the best drug treatment for severe heart disease

Is personalized medicine cost-effective? University of Alabama at Birmingham researcher Nita Limdi, Pharm.D., Ph.D., and colleagues across the United States have answered that question for one medical treatment.

15 May 2020

Indo-Mediterranean style diets can cause decline in pre-heart failure, arrhythmias

The role of diets in the pathogenesis of cardiac dysfunction is controversial. However, it is well known that Western diet causes oxidative stress and has pro-inflammatory effects, whereas Mediterranean style diets are anti-inflammatory.

11 May 2020

IONTAS announces a new collaboration to identify novel immunotherapy targets

Antibody discovery agreement will support the development of new therapeutics for acute and chronic inflammatory syndromes.

From FairJourney Biologics 7 May 2020

Cholesterol lowering drugs can improve composition of gut bacteria in obese individuals

The human gut microbiota consists of trillions of bacteria, fungi and virus constituting an inner chemical factory producing a multitude of microbial compounds affecting immunity, neurobiology and metabolism of the human host.

7 May 2020

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

30 Apr 2020

Apple Watch ECG app may detect coronary ischemia

Digitization can do a lot in medicine, even save lives. This is shown by the specific case of an 80-year-old patient in Mainz.

30 Apr 2020

New consensus on managing AMI patients during COVID-19 released

The Society for Cardiovascular Angiography and Interventions, along with the American College of Cardiology and American College of Emergency Physicians have released a consensus statement that provides recommendations for a systematic approach for the care of patients with an acute myocardial infarction during the coronavirus disease-2019 pandemic.

21 Apr 2020

Male-female cardiac repair differences found in heart failure survival after heart attack

The short-term acute inflammatory response triggered to mend injured cardiac tissue following a heart attack can lead to weakening of the heart's pumping function if the inflammation remains active over the long-term.

20 Apr 2020

Study highlights gap between men and women who suffer from heart attack

Women are more likely to die after a heart attack than men because they are often not prescribed the drugs they need. That's the result of research presented today on ACVC Essentials 4U, a scientific platform of the European Society of Cardiology (ESC).

17 Apr 2020

'Off-the-shelf' artificial cardiac patch improves heart attack recovery in rat and pig models

Researchers from North Carolina State University have developed an "off-the-shelf" artificial cardiac patch that can deliver cardiac cell-derived healing factors directly to the site of heart attack injury. In a rat model of heart attack, the freezable, cell-free patch improved recovery.

8 Apr 2020

New molecular mechanism that regulates the sentinel cells of the immune system

A study suggests that it may be possible to regulate macrophages with drugs that modulate the nuclear receptor RXR.

3 Apr 2020

New 3D bioprinting technologies to create cardiovascular tissue

Cardiovascular disease is the leading cause of death worldwide, with over 17 million per year according to the World Health Organization.

From IDTechEx Ltd 31 Mar 2020

Horizon Discovery and Pharmahungary report positive early-stage results for novel micro-RNA therapeutic for ischemic heart diseases

Horizon Discovery Group plc and Pharmahungary Group announced positive early-stage results for a novel micro-RNA therapeutic for ischemic heart diseases.

31 Mar 2020

TWILIGHT trial: Brilinta reduces bleeding compared to dual therapy in high-risk coronary patients

Results from two subgroup analyses of the Phase IV independent TWILIGHT trial funded by AstraZeneca showed Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding over 12 months compared to aspirin plus Brilinta in high-risk coronary patients.

From AstraZeneca 30 Mar 2020

New microfluidic chip can mimic hypoxic conditions after a heart attack

Researchers led by biomedical engineers at Tufts University invented a microfluidic chip containing cardiac cells that is capable of mimicking hypoxic conditions following a heart attack - specifically when an artery is blocked in the heart and then unblocked after treatment.

30 Mar 2020

Taking ticagrelor alone better for patients with complex heart disease

Patients with complex heart disease who stopped taking aspirin three months after the insertion of one or more coronary stents and then took the anti-platelet medication ticagrelor alone for a year had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor over the same period.

30 Mar 2020

Treatment with ticagrelor alone reduces adverse events in patients with diabetes

Patients with diabetes who stopped taking aspirin three months after the insertion of a coronary stent and then took the anti-platelet medication ticagrelor alone for a year had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor for a year.

30 Mar 2020

Researchers develop a 'cardiac patch with bioink' to repair the heart

The heart is the driving force of circulating blood in the body and pumps blood to the entire body by repeating contraction and relaxation of the heart muscles continuously.

30 Mar 2020

Trials find invasive surgery is no better than medication at reducing heart attack risk

Among stable ischemic heart disease patients, invasive procedures do not reduce heart attack or death risk more than medication.

30 Mar 2020

Myocardial Infarction News and Research

RAAS inhibitors are safe to use in COVID-19 patients, study shows

Precision medicine can determine the best drug treatment for severe heart disease

Indo-Mediterranean style diets can cause decline in pre-heart failure, arrhythmias

IONTAS announces a new collaboration to identify novel immunotherapy targets

Cholesterol lowering drugs can improve composition of gut bacteria in obese individuals

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

Apple Watch ECG app may detect coronary ischemia

New consensus on managing AMI patients during COVID-19 released

Male-female cardiac repair differences found in heart failure survival after heart attack

Study highlights gap between men and women who suffer from heart attack

'Off-the-shelf' artificial cardiac patch improves heart attack recovery in rat and pig models

New molecular mechanism that regulates the sentinel cells of the immune system

New 3D bioprinting technologies to create cardiovascular tissue

Horizon Discovery and Pharmahungary report positive early-stage results for novel micro-RNA therapeutic for ischemic heart diseases

TWILIGHT trial: Brilinta reduces bleeding compared to dual therapy in high-risk coronary patients

New microfluidic chip can mimic hypoxic conditions after a heart attack

Taking ticagrelor alone better for patients with complex heart disease

Treatment with ticagrelor alone reduces adverse events in patients with diabetes

Researchers develop a 'cardiac patch with bioink' to repair the heart

Trials find invasive surgery is no better than medication at reducing heart attack risk

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News